Surmodics to Webcast Third Quarter Fiscal 2019 Earnings Conference Call on July 31
July 23 2019 - 8:30AM
Business Wire
Webcast is Live at 4 p.m. (CT)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that it will host a live webcast of its
third quarter fiscal 2019 conference call on Wednesday, July 31, at
4 p.m. CT (5 p.m. ET). The Company will issue an earnings news
release after the market closes that afternoon.
Gary Maharaj, president and chief executive officer, and Tim
Arens, vice president of finance and chief financial officer, will
recap the third quarter fiscal 2019 financial results and
accomplishments. To access the webcast, go to the investor
relations portion of the Company’s website at
https://surmodics.gcs-web.com the day of the conference call and
click on the webcast icon.
An audio replay will be available beginning at 7 p.m. CT on
Wednesday, July 31, until 7 p.m. CT on Wednesday, August 7, and can
be accessed by dialing 888-203-1112 and entering conference call ID
passcode 6653187. In addition, the conference call audio and
transcript will be archived on the Company’s website following the
call.
About Surmodics, Inc.
Surmodics is the global leader in surface modification
technologies for intravascular medical devices and a leading
provider of chemical components for in vitro diagnostic (IVD)
immunoassay tests and microarrays. Surmodics is pursuing highly
differentiated whole-product solutions that are designed to address
unmet clinical needs for its medical device customers and
engineered to the most demanding requirements. This key growth
strategy leverages the combination of the Company’s expertise in
proprietary surface technologies, along with enhanced device
design, development and manufacturing capabilities. The Company
mission remains to improve the detection and treatment of disease.
Surmodics is headquartered in Eden Prairie, Minnesota. For more
information, visit www.surmodics.com. The content of Surmodics’
website is not part of this press release or part of any filings
that the company makes with the SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190723005129/en/
Tim Arens 952-500-7000 ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024